+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Multivariate analysis of long-term results after an axillobifemoral and aortobifemoral bypass in patients with aortoiliac occlusive disease



Multivariate analysis of long-term results after an axillobifemoral and aortobifemoral bypass in patients with aortoiliac occlusive disease



Journal of Cardiovascular Surgery 41(6): 905-910



Controversy still remains regarding the long-term results and indications for axillofemoral bypass (AxFB). A comparison of axillobifemoral bypass (AxBFB) and aortobifemoral bypass (ABFB) was thus conducted to determine whether AxFB is an acceptable alternative vascular procedure to anatomic bypass for high-risk patients. Sixty-three patients who underwent a total of 25 AxBFBs and 38 ABFBs for aortoiliac occlusive disease were reviewed retrospectively, and both univariate and multivarate analyses were perfomed. The overall survival was 82.8% at five years. A univariate analysis revealed significantly lower survival rates for patients with limb-threatening ischemia, coronary disease, and cerebrovascular disease. A multivariate analysis disclosed no significant factors influencing survival rates. The overall primary patency was 79.8% at five years. The primary patency rates for AxBFB (67.7% at five years) were significantly lower than for ABFB (88.5% at five years) based on a univariate analysis (p=0.0045). In addition, the secondary patency rates for AxBFB (80.3% at five years) were significantly lower than for ABFB (96.5% at five years, p=0.0025). A multivariate analysis disclosed significantly lower primary patency rates for grafts with a higher angiographic outflow score and simultaneous infrainguinal reconstructive procedures, but the differences between AxBFB and ABFB were not significant. The survival and primary patency for the AxBFB group were both inferior to the ABFB group, however a multivarate analysis disclosed no significant differences between the two groups. Poor femoral run-off and the presence of synchronous infrainguinal reconstructive procedures significantly affected graft patency, and these factors modulated the patency of AxBFB. AxFB for aortoiliac occlusive disease is therefore considered to be an acceptable procedure in appropriately selected patients.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046744814

Download citation: RISBibTeXText

PMID: 11232974


Related references

Long-term results of endarterectomy, anatomic bypass and extraanatomic bypass for aortoiliac occlusive disease. Surgery Today 28(2): 151-155, 1998

Association between statin use and perioperative mortality after aortobifemoral bypass in patients with aortoiliac occlusive disease. Journal of Vascular Surgery 70(2): 509-515, 2019

Outcomes after redo aortobifemoral bypass for aortoiliac occlusive disease. Journal of Vascular Surgery 60(2): 346-355.E1, 2014

Experimental laparoscopic aortobifemoral bypass for occlusive aortoiliac disease. Canadian Journal of Surgery. Journal Canadien de Chirurgie 39(6): 451-455, 1996

Aortobifemoral bypass via paramedian incision and retroperitoneal approach for aortoiliac occlusive disease. Acta Chirurgica Belgica 113(3): 182-186, 2014

Clinical profile of aortoiliac occlusive disease and outcomes of aortobifemoral bypass in India. Journal of Vascular Surgery 57(2 Suppl): 20s-25s, 2013

Robot-assisted laparoscopic aortobifemoral bypass for aortoiliac occlusive disease: A report of two cases. Journal of Vascular Surgery 36(5): 1079-1082, 2002

Anesthetic management of descending thoracic aortobifemoral bypass for aortoiliac occlusive disease: Our experience. Saudi Journal of Anaesthesia 8(1): 97, 2014

Use of thoracic aortobifemoral artery bypass grafting as an alternative procedure for occlusive aortoiliac disease. American Surgeon 51(10): 573-576, 1985

Successful total robotic-assisted aortobifemoral bypass for treatment of complicated aortoiliac occlusive disease. Vascular and Endovascular Surgery 45(4): 340-344, 2011

Robot-assisted laparoscopic aortobifemoral bypass for aortoiliac occlusive disease: early clinical experience. European Journal of Vascular and Endovascular Surgery 29(6): 586-590, 2005

A comparison between aortobifemoral bypass and aortoiliac kissing stents in patients with complex aortoiliac obstructive disease. Journal of Vascular Surgery 65(1): 99, 2017

Hand-assisted laparoscopic aortobifemoral bypass for occlusive disease. Early and mid-term results. European Journal of Vascular and Endovascular Surgery 30(5): 489-493, 2005

Long-term outcome of aortofemoral bypass for aortoiliac occlusive disease. Annals of the Academy of Medicine, Singapore 29(4): 434-438, 2000

Endovascular intervention of aortoiliac occlusive disease in high-risk patients using the kissing stents technique: long-term results. Catheterization and Cardiovascular Interventions 60(3): 320-326, 2003